AbbVie News Center - News
Jan 13, 2025 · AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
AbbVie Completes Acquisition of ImmunoGen - Feb 12, 2024
Feb 12, 2024 · Through focused R&D efforts, AbbVie has developed novel ADC technology and has unique strengths in antibody engineering, drug linker chemistry and toxin research. …
AbbVie Completes Acquisition of Cerevel Therapeutics
NORTH CHICAGO, Ill., Aug. 1, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) today announced that it has completed its acquisition of Cerevel Therapeutics (NASDAQ: CERE). With the …
AbbVie to Acquire Landos Biopharma, Further Strengthening its
Mar 25, 2024 · NORTH CHICAGO, Ill. and NEW YORK, March 25, 2024 / PRNewswire / -- AbbVie Inc. (NYSE: ABBV) ("AbbVie") and Landos Biopharma, Inc. (NASDAQ: LABP) …
AbbVie to Acquire ImmunoGen, including its Flagship Cancer
Nov 30, 2023 · "The acquisition of ImmunoGen demonstrates our commitment to deliver on our long-term growth strategy and enables AbbVie to further diversify our oncology pipeline across …
AbbVie to Acquire Nimble Therapeutics, Further Strengthening …
Dec 13, 2024 · NORTH CHICAGO, Ill. and MADISON, Wis., Dec. 13, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) and Nimble Therapeutics today announced a definitive agreement …
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
Feb 2, 2024 · Delivers Fourth-Quarter Net Revenues of $14.301 Billion, a Decrease of 5.4 Percent Announced Definitive Transaction Agreements to Acquire ImmunoGen and Cerevel …
AbbVie to Acquire Cerevel Therapeutics in Transformative ... - News
Dec 6, 2023 · NORTH CHICAGO, Ill. and CAMBRIDGE, Mass., Dec. 6, 2023 / PRNewswire / -- AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) today announced a …
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in …
Oct 28, 2024 · NORTH CHICAGO, Ill. and BOSTON, Oct. 28, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) and Aliada Therapeutics today announced a definitive agreement under which …
AbbVie Acquires Celsius Therapeutics - Jun 27, 2024 - AbbVie …
NORTH CHICAGO, Ill., June 27, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) announced today the acquisition of Celsius Therapeutics, Inc. ("Celsius"), a privately held biotechnology …